markets accounts for 2 of the 3 tracked stories, while 1 other category carries the remainder. Adobe Inc. is most often covered alongside Adobe Acrobat, which appears in 1 of these 3 stories. They are less corroborated than the beat average, carrying 2 original sources each against 2.7 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Adobe Inc.
markets accounts for 2 of the 3 tracked stories, while 1 other category carries the remainder. Adobe Inc. is most often covered alongside Adobe Acrobat, which appears in 1 of these 3 stories. They are less corroborated than the beat average, carrying 2 original sources each against 2.7 for the same window. Across a 101-day span, the pace is roughly 0.2 stories per week. Their average consequence score of 5.7 runs below the beat's 6.4 for that window. This profile follows 3 Finance stories mentioning Adobe Inc. across the period from March 7, 2026 to June 15, 2026.
Stories tracked
3
Per week
0.2
Sources per story
2
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 1955 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Adobe Inc.. Shared-story counts are live from our verified record — not editorial picks.
JPMorgan chopped its Adobe price target by $80 to $340 after management cut organic ARR growth guidance by 2pp, despite a Q2 2026 top- and bottom-line beat. ADBE shares hit a 12-month low, highlighting Wall Street's impatience with the return on AI investments.
Union Bancaire Privee UBP SA significantly expanded its position in Apple Inc. during the fourth quarter, increasing its stake by 77.6%. The Swiss private bank now holds over 1.15 million shares, signaling strong institutional confidence in the tech giant's long-term growth trajectory.
Investors are weighing the defensive stability of healthcare giant DaVita against the high-growth potential of newly public Figma. While DaVita offers a moat-protected cash flow model favored by value investors, Figma represents the next frontier of collaborative AI-driven design tools.